Share on StockTwits

Ampio Pharmaceuticals (NASDAQ:AMPE) posted its quarterly earnings results on Tuesday. The company reported ($0.17) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.24) by $0.07, AnalystRatingsNetwork reports.

Ampio Pharmaceuticals (NASDAQ:AMPE) opened at 6.48 on Tuesday. Ampio Pharmaceuticals has a 52-week low of $5.07 and a 52-week high of $10.86. The stock has a 50-day moving average of $7.05 and a 200-day moving average of $7.10. The company’s market cap is $336.4 million.

A number of research firms have recently commented on AMPE. Analysts at Jefferies Group initiated coverage on shares of Ampio Pharmaceuticals in a research note on Friday, June 27th. They set a “buy” rating and a $14.00 price target on the stock. Analysts at Aegis reiterated a “buy” rating on shares of Ampio Pharmaceuticals in a research note on Wednesday, June 25th.

Ampio Pharmaceuticals, Inc (NASDAQ:AMPE) is a development-stage biopharmaceutical company focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.

Receive News & Ratings for Ampio Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.